rubimaillin has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, G; Gong, XP; Li, J; Pi, HF; Song, YY; Xiao, M; Zhang, JL | 1 |
| Wang, D; Zhang, Y; Zhou, J; Zhou, S; Zhou, T | 1 |
2 other study(ies) available for rubimaillin and Disease Models, Animal
| Article | Year |
|---|---|
Anti-inflammatory Activity of Mollugin on DSS-induced Colitis in Mice.
Topics: Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Drugs, Chinese Herbal; Humans; Interleukin-1beta; Mice; Pyrans; Rubia; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2020 |
Regulation of NF-κB/MAPK signaling pathway attenuates the acute lung inflammation in Klebsiella pneumonia rats by mollugin treatment.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Female; Klebsiella Infections; Klebsiella pneumoniae; Lung; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; NF-kappa B; Pneumonia; Pyrans; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction | 2019 |